Improved outcomes of clinical trials for substance use disorders
The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse is seeking research services to improve outcomes of clinical trials for substance use disorders, including stimulant and opioid use disorders. The objective is to manage and analyze harmonized datasets of these clinical trials to examine novel and clinically relevant outcome measures beyond total abstinence, with the goal of potentially improving the effect size of medications tested. Proposals will be evaluated on technical and scientific capability, personnel qualifications and experience, and price reasonableness. Quotes are due by 8:00 PM Eastern Time on August 15, 2024 and must be submitted electronically to the Contracting Officer.
This is a total small business set-aside acquisition for a firm-fixed-price purchase order with a 12-month period of performance from September 3, 2024 to September 2, 2025. The North American Industry Classification System (NAICS) code is 541690 - Other Scientific and Technical Consulting Services, and the Product Service Code (PSC) is AN21-P - Health R&D Services; Health Research And Training; Basic Research. The place of performance is Baltimore, MD, USA.
75N95024Q00453 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
8/8/24, 1:34 PM Improved outcomes of clinical trials for substance use disorders
The National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services National Institutes of Health, is seeking information on the availability and capability of qualified businesses to potentially perform research on improved outcomes in clinical trials for substance use disorders (SUDs), including stimulant and opioid use disorders. Specifically, NIDA aims to examine reduced use and improved function rather than total abstinence as endpoints, to see whether such endpoints may improve the effect size of medications tested for SUDs. Respondents should provide information on their qualifications, personnel, and relevant contracts to support this data management and analysis project. The response deadline is July 24, 2024 at 12:00 PM Eastern Time.
This procurement opportunity is not set aside for any specific business size category. There is no mention of any potential incumbents or current contractors. The notice does not provide any details on the potential award value or budget range for this requirement. The key numerical details provided indicate that NIDA is seeking to manage and analyze harmonized datasets of SUD clinical trials to investigate this research approach.
75N95024Q00453 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
7/17/24, 3:31 PM Improved outcomes of clinical trials for substance use disorders
This Award Notice announces that the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) has awarded contract 75N95024P00505 to Harmonized Health Analytics LLC for $74,972.36. The contract is for improved outcomes of clinical trials for substance use disorders, which is a Total Small Business set-aside opportunity. The contract was awarded on August 26, 2024.
75N95024Q00453 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
8/26/24, 1:24 PM